Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Multiple MyelomaBreast Cancer
Interventions
DRUG

Zoledronic acid

Trial Locations (7)

15232

Hillman Cancer Center, Pittsburgh

23230

Virginia Cancer Institute Virginia Cancer Center, Richmond

90069

Oncotherapeutics, West Hollywood

Unknown

Rocky Mountain Cancer Centers RMCC, Greenwood Village

06856

Norwalk Hospital, Norwalk

84112-0550

Huntsman Cancer Institute Univ. of Utah, Salt Lake City

05404

University of Vermont Fletcher Allen Health Care, Burlington

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY